|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1996-10-21
|
|
pubmed:abstractText |
This study was undertaken to evaluate the dose tolerability and safety of a chronic ascending twice-daily (b.i.d.) dosage regimen of < or = 700 mg/day lamotrigine (LTG) and to include determination of the LTG pharmacokinetic profile at doses > or = 500 mg/day in patients receiving concomitant enzyme-inducing antiepileptic drugs (AEDs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0013-9580
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
857-62
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8814098-Adolescent,
pubmed-meshheading:8814098-Adult,
pubmed-meshheading:8814098-Anticonvulsants,
pubmed-meshheading:8814098-Diplopia,
pubmed-meshheading:8814098-Dose-Response Relationship, Drug,
pubmed-meshheading:8814098-Double-Blind Method,
pubmed-meshheading:8814098-Drug Administration Schedule,
pubmed-meshheading:8814098-Drug Therapy, Combination,
pubmed-meshheading:8814098-Epilepsy,
pubmed-meshheading:8814098-Headache,
pubmed-meshheading:8814098-Humans,
pubmed-meshheading:8814098-Male,
pubmed-meshheading:8814098-Middle Aged,
pubmed-meshheading:8814098-Placebos,
pubmed-meshheading:8814098-Sleep Stages,
pubmed-meshheading:8814098-Treatment Outcome,
pubmed-meshheading:8814098-Triazines
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
|
|
pubmed:affiliation |
Department of Neurology, University of Utah School of Medicine, Salt Lake City 84132, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
